VoluMetrix develops the NIVA system, which utilizes non-invasive venous waveform analysis to monitor heart failure in patients. This technology provides clinicians with real-time insights into patient health, enhancing the management of cardiovascular conditions.
Funding
$50K raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Heart failure management relies on invasive procedures or infrequent monitoring, limiting timely intervention and potentially leading to adverse events. Current methods often fail to provide continuous, real-time insights into a patient's hemodynamic status outside of a clinical setting. This lack of readily available data hinders proactive adjustments to treatment plans and can result in hospital readmissions.
Solution
VoluMetrix offers the NIVA system, a non-invasive venous waveform analysis technology designed to continuously monitor heart failure patients. NIVA provides clinicians with real-time data on a patient's cardiovascular condition, enabling more informed and timely clinical decision-making. By leveraging waveform analysis, the system aims to improve patient outcomes through enhanced monitoring and proactive management of heart failure. The technology offers a new approach to vital monitoring, providing a continuous stream of data that can help clinicians and patients gain better insights into their health.
Target Audience
The primary target audience includes hospitals, healthcare providers, and physicians involved in the management of heart failure patients, as well as patients in need of a monitoring solution.
Features
- Non-invasive venous waveform analysis for continuous hemodynamic monitoring
- Real-time data insights into patient's cardiovascular condition
- Early detection of changes in hemodynamic status